Voyager Therapeutics (VYGR) Revenue Growth (1y) (2016 - 2026)
Powered by 
Analysis
Voyager Therapeutics (VYGR) Revenue Growth (1y) (2016 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.60 Bn | 9.76 Bn | 112.79 Mn | 24.14% |
| 2 | CRISPR Therapeutics AG | 5.39 Bn | 5.39 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.98 Bn | 3.68 Bn | 55.72 Mn | 65.65% |
| 4 | Legend Biotech | 3.97 Bn | 3.00 Bn | 251.50 Mn | 51.90% |
| 5 | uniQure | 3.09 Bn | 3.09 Bn | 5.49 Mn | - |
| 6 | Beam Therapeutics | 3.06 Bn | 3.06 Bn | - | - |
| 7 | Precigen | 2.54 Bn | 2.54 Bn | 52.17 Mn | - |
| 8 | Sarepta Therapeutics | 2.38 Bn | 1.58 Bn | 251.87 Mn | -34.34% |
| 9 | Vericel | 2.06 Bn | 1.89 Bn | 56.40 Mn | 22.48% |
| 10 | Voyager Therapeutics | 215.07 Mn | 98.73 Mn | - | -38.46% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -38.46% |
| Mar 31, 2026 | -60.00% |
| Dec 31, 2025 | 144.28% |
| Sep 30, 2025 | -45.59% |
| Jun 30, 2025 | -82.43% |
| Mar 31, 2025 | -66.69% |
| Dec 31, 2024 | -93.03% |
| Sep 30, 2024 | 433.79% |
| Jun 30, 2024 | 504.08% |
| Mar 31, 2024 | -87.03% |
| Dec 31, 2023 | 5,910.39% |
| Sep 30, 2023 | -88.77% |
| Jun 30, 2023 | 588.20% |
| Mar 31, 2023 | 22,769.30% |
| Dec 31, 2022 | -105.52% |
| Sep 30, 2022 | 2,672.33% |
| Jun 30, 2022 | -47.53% |
| Mar 31, 2022 | -89.88% |
| Dec 31, 2021 | 329.45% |
| Sep 30, 2021 | -98.74% |